Utility of contrast-enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 4, 2011, Pages 759-764

  Masuzaki, Ryota ^a   Shiina, Shuichiro ^a   Tateishi, Ryosuke ^a   Yoshida, Haruhiko ^a   Goto, Eriko ^a   Sugioka, Yosuke ^b   Kondo, Yuji ^a   Goto, Tadashi ^a   Ikeda, Hitoshi ^b   Omata, Masao ^c   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^c Yamanashi Prefectural Hospital Organization   (Japan)

Author keywords

Contrast enhanced ultrasonography; Hepatocellular carcinoma; Radiofrequency ablation

Indexed keywords

ALBUMIN; PERFLUBUTANE;

ADULT; AGED; ARTICLE; BILE DUCT BLEEDING; BILE DUCT DISEASE; BURN; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCED ULTRASONOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; ECHOGRAPHY; FEMALE; HEMATOTHORAX; HEMOPERITONEUM; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; TUMOR GROWTH;

EID: 79952827661     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06559.x     Document Type: Article

References (21)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005; 55: 74-108.
2. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36.
3. Rossi S, Di Stasi M, Buscarini E etal. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am. J. Roentgenol. 1996; 167: 759-68.
4. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999; 210: 655-61.
5. Shiina S, Teratani T, Obi S etal. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129: 122-30.
6. Ikai I, Arii S, Okazaki M etal. Report of the 17th nationwide follow-up survey of primary liver cancer in Japan. Hepatol. Res. 2007; 37: 676-91.
7. Tanaka S, Kitamura T, Nakanishi K, Okuda S, Kojima J, Fujimoto I. Recent advances in ultrasonographic diagnosis of hepatocellular carcinoma. Cancer 1989; 63: 1313-7.
8. Nakai M, Sato M, Sahara S etal. Radiofrequency ablation assisted by real-time virtual sonography and CT for hepatocellular carcinoma undetectable by conventional sonography. Cardiovasc Intervent Radiol. 2009; 32: 62-9.
9. Sato M, Watanabe Y, Tokui K, Kawachi K, Sugata S, Ikezoe JC. T-guided treatment of ultrasonically invisible hepatocellular carcinoma. Am. J. Gastroenterol. 2000; 95: 2102-6.
10. Fujimoto M, Moriyasu F, Nishikawa K, Nada T, Okuma M. Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings. AJR Am. J. Roentgenol. 1994; 163: 1099-104.
11. Kudo M, Tomita S, Tochio H etal. Sonography with intraarterial infusion of carbon dioxide microbubbles (sonographic angiography): value in differential diagnosis of hepatic tumors. AJR Am. J. Roentgenol. 1992; 158: 65-74.
12. Kudo M. New sonographic techniques for the diagnosis and treatment of hepatocellular carcinoma. Hepatol. Res. 2007; 37 (Suppl. 2): S193-9.
13. Moriyasu F, Itoh K. Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions: phase 3 multicenter clinical trial. AJR Am. J. Roentgenol. 2009; 193: 86-95.
14. Numata K, Morimoto M, Ogura T etal. Ablation therapy guided by contrast-enhanced sonography with Sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography. J. Ultrasound Med. 2008; 27: 395-406.
15. Minami Y, Kudo M, Hatanaka K etal. Radiofrequency ablation guided by contrast harmonic sonography using perfluorocarbon microbubbles (Sonazoid) for hepatic malignancies: an initial experience. Liver Int. 2010; 30: 759-64.
16. Torzilli G, Minagawa M, Takayama T etal. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 1999; 30: 889-93.
17. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48900 necropsies. Cancer 1954; 7: 462-503.
18. Tateishi R, Shiina S, Teratani T etal. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005; 103: 1201-9.
19. Tanimoto A, Yuasa Y, Shinmoto H etal. Superparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function. Radiology 2002; 222: 661-6.
20. Kondo Y, Yoshida H, Tateishi R, Shiina S, Kawabe T, Omata M. Percutaneous radiofrequency ablation of liver cancer in the hepatic dome using the intrapleural fluid infusion technique. Br. J. Surg. 2008; 95: 996-1004.
21. Kondo Y, Yoshida H, Shiina S, Tateishi R, Teratani T, Omata M. Artificial ascites technique for percutaneous radiofrequency ablation of liver cancer adjacent to the gastrointestinal tract. Br. J. Surg. 2006; 93: 1277-82.